Acute opthalmologic complications during the use of oral contraceptives.
D000328:Adult; D000605:Amino Alcohols / Q000627:therapeutic use; D001157:Arterial Occlusive Diseases / Q000139:chemically induced / Q000188:drug therapy; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003280:Contraceptives, Oral, Synthetic / Q000009:adverse effects*; D004338:Drug Combinations; D004997:Ethinyl Estradiol / Q000009:adverse effects; D005040:Ethynodiol Diacetate / Q000009:adverse effects; D005260:Female; D006801:Humans; D008656:Mestranol / Q000009:adverse effects; D009539:Nicotinic Acids / Q000031:analogs & derivatives / Q000627:therapeutic use; D009640:Norethindrone / Q000009:adverse effects; D012161:Retinal Artery; D013806:Theophylline / Q000031:analogs & derivatives / Q000627:therapeutic use; D014786:Vision Disorders / Q000139:chemically induced* / Q000188:drug therapy; D014859:Warfarin / Q000627:therapeutic use
D000605:Amino Alcohols; D003276:Contraceptives, Oral; D003280:Contraceptives, Oral, Synthetic; D004338:Drug Combinations; D009539:Nicotinic Acids; D004997:Ethinyl Estradiol; D014859:Warfarin; D005040:Ethynodiol Diacetate; D008656:Mestranol; D013806:Theophylline; D009640:Norethindrone